Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia

Background/Aims Waldenström macroglobulinemia (WM) is a rare lymphoproliferative disorder that usually follows an indolent clinical course. However, some patients show an aggressive clinical course leading to death. We explored the risk factors predicting poor prognosis in WM patients. Methods We re...

Full description

Bibliographic Details

Published in:	The Korean Journal of Internal Medicine
Main Authors:	Jang Ho Cho, Joon-Ho Shim, Sang Eun Yoon, Hee-Jin Kim, Sun-Hee Kim, Young Hyeh Ko, Seung-Tae Lee, Kihyun Kim, Won Seog Kim, Seok Jin Kim
Format:	Article
Language:	English
Published:	The Korean Association of Internal Medicine 2021-05-01
Subjects:	waldenstrom macroglobulinemia amyloidosis survival rituximab
Online Access:	http://www.kjim.org/upload/pdf/kjim-2019-367.pdf